13 unchanged sentences
In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States dollars.
−Removed: All references to "CDN$" refer to Canadian dollars and all references to "common shares" refer to the common shares in our capital stock.
+Added: All references to "CAD$" refer to Canadian dollars and all references to "common shares" refer to the common shares in our capital stock.
As used in this quarterly report, the terms "we", "us", "our" and "Company" mean Company and/or our subsidiaries, unless otherwise indicated.
31 unchanged sentences
The United States Patent Trademark Office (USPTO) (Water Producing System for a Liquid Transfer Mat) has notified the Company patent number 12231085 was issued of February 18, 2025.
+Added: On April 4, 2025 the Company announced the filing of provisional patent number 63/782/745 for the Scalable Automated Oxyhydrogen Production, Storage, and Utilization System.
The continuation of our business is dependent upon obtaining further financing, a successful program of development, and, finally, achieving a profitable level of operations.
23 unchanged sentences
Research and Development
−Removed: We have incurred $621,345 in research and development expenditures over the last two fiscal years and $61,686 during the six months ended February 28, 2025.
+Added: We have incurred $621,345 in research and development expenditures over the last two fiscal years and $95,832 during the nine-months ended May 31, 2025.
There is strong competition relating to all aspects of the resource and technology sectors.
34 unchanged sentences
Results of Operations
−Removed: The following summary of our results of operations should be read in conjunction with our financial statements for the quarter ended February 28, 2025, which are included herein.
−Removed: Our operating results for the three months ended February 28, 2025 and February 29 2024, and the changes between those periods for the respective items are summarized as follows:
+Added: The following summary of our results of operations should be read in conjunction with our financial statements for the quarter ended May 31, 2025, which are included herein.
+Added: Our operating results for the three months ended May 31, 2025 and May 31, 2024, and the changes between those periods for the respective items are summarized as follows:
Three Months Ended
−Removed: February 28, February 29,
−Removed: 2025 2024 Change
Revenue (cost recovery)
8 unchanged sentences
Net loss (income)
−Removed: Our financial statements report no revenue for the three months ended February 28, 2025, and February 29, 2024.
−Removed: Our financial statements report a net loss of $115,527 for the three-month period ended February 28, 2025, compared to a net loss of $147,368 for the three-month period ended February 29, 2024.
−Removed: Our net loss decreased by $31,841 for the three-month period ended February 28, 2025 primarily due to the increase in research and development of $18,243, a reduction in consulting fees of $22,990 and increase in other income, which consisted of foreign exchange gains.
−Removed: The increase in research and development primarily consisted of work performed supporting our patent filing claims.
−Removed: Our operating costs were lower by $13,109 for February 28, 2025, compared to February 29, 2024 primarily from cost containment measures offset by increases in costs for patent filings.
−Removed: Our operating results for the six months ended February 28, 2025 and February 29 2024, and the changes between those periods for the respective items are summarized as follows:
−Removed: SIX MONTHS ENDED
−Removed: February 28, February 29,
−Removed: 2025 2024 Change
−Removed: Revenue $ - $ - $ -
+Added: Our financial statements report no revenue for the three-months ended May 31, 2025, and 2024.
+Added: Our financial statements report a net loss of $130,364 for the three-month period ended May 31, 2025, compared to a net loss of $287,901 for the three-month period ended May 31, 2024.
+Added: Our net loss decreased by $157,537 for the three-month period ended May 31, 2025 primarily due to the decrease other expenses of $113,422 primarily due to losses on marketable securities, a reduction in consulting fees of $45,024, and filing fees of $28,505, offset by increases in research and development of $12,263 and Professional fees of $5,613.
+Added: The increases in research and development and professional fees primarily consisted of work performed supporting our patent filing claims.
+Added: Our operating costs were lower by $47,508 for May 31, 2025, compared to May 31, 2024 primarily from cost containment measures offset by increases in costs for patent filings.
+Added: Our operating results for the nine-months ended May 31, 2025 and 2024, and the changes between those periods for the respective items are summarized as follows:
+Added: NINE MONTHS ENDED
General and administrative
7 unchanged sentences
Net loss (income)
−Removed: Our financial statements report no revenue for the six months ended February 28, 2025, and February 29, 2024.
−Removed: Our financial statements report a net loss of $198,657 for the six month period ended February 28, 2025, compared to a net loss of $557,116 for the six month period ended February 29, 2024.
−Removed: Our net loss decreased by $358,459 for the six month period ended February 28, 2025 primarily due to cost containment measures and focus on our research and development work supporting our patent filings.
+Added: Our financial statements report no revenue for the nine-months ended May 31, 2025, and 2024.
+Added: Our financial statements report a net loss of $329,021 for the nine-month period ended May 31, 2025, compared to a net loss of $845,233 for the nine-month period ended May 31, 2024.
+Added: Our net loss decreased by $516,212 for the nine-month period ended May 31, 2025 primarily due to cost containment measures and focus on our research and development work supporting our patent filings.
Other income primarily consisted of non-cash unrealized gain of $377,803 on mark to market and realized losses on disposition of $352,239 on marketable securities.
The decrease in exploration expenses primarily consisted of reporting work performed in the prior year on technical reporting that was not performed in the current period.
−Removed: Our operating costs were lower by $171,456 for February 28, 2025, compared to February 29, 2024 primarily from cost containment measures and focusing our expenses on supporting our patent filings.
+Added: Our operating costs were lower by $219,180 for May 31, 2025, compared to May 31, 2024 primarily from cost containment measures and focusing our expenses on supporting our patent filings.
Liquidity and Financial Condition
−Removed: Working Capital February 28, August 31,
+Added: Working Capital
Current assets
1 unchanged sentence
Working capital (deficit)
−Removed: As at February 28, 2025, we had $282,667 in current liabilities, which is lower by $33,365 when compared to current liabilities as at August 31, 2024.
−Removed: February 28, February 29,
−Removed: Cash Flows 2025 2024
+Added: As at May 31, 2025, we had $309,825 in current liabilities, which is lower by $6,208 when compared to current liabilities as at August 31, 2024.
Cash flows used in operating activities
Cash flows from investing activities
+Added: Cash flows from financing activities
Net (decrease) increase in cash during year
Operating Activities
−Removed: Net cash used in operating activities was $195,628 in the six months ended February 28, 2025 compared with net cash used in operating activities of $373,224 in the same period in 2024.
+Added: Net cash used in operating activities was $282,534 in the nine-months ended May31, 2025 compared with net cash used in operating activities of $582,444 in the same period in 2024.
Investing Activities
−Removed: Net cash provided by investing activities was $75,947 and $381,334 in the six months ended February 28, 2025 and February 29, 2024, respectively.
+Added: Net cash provided by investing activities was $75,947 and $520,590 in the nine-months ended May 31, 2025 and 2024, respectively.
Financing Activities
−Removed: The Company had no financing activities in the six months ended February 28, 2025 and February 29, 2024.
+Added: During the nine-months ended May 31, 2025, the company issue 1,040,000 common shares at $0.0722 (CAD$0.10) for a total of $73,084 net of fees.
+Added: The Company had no financing activities in the nine-months ended May 31, 2024.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.